Piramal Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	12,236	3,889	3,714	1,956	2,281
Short-Term Investments	1,318	-	-	1	7.1
Trading Asset Securities	-	195.6	1,447	4,271	504
Cash & Short-Term Investments	13,554	4,085	5,160	6,228	2,792
Cash Growth	231.80%	-20.84%	-17.14%	123.06%	-28.00%
Accounts Receivable	21,577	23,757	21,348	18,144	18,086
Other Receivables	-	453.7	171.3	35.6	141.9
Receivables	21,577	24,211	21,519	18,179	18,228
Inventory	30,644	23,127	21,759	16,814	13,888
Prepaid Expenses	-	791.8	640.2	765.7	695.5
Restricted Cash	-	1,125	1,112	1,021	913.5
Other Current Assets	6,141	4,630	4,454	5,347	4,155
Total Current Assets	71,917	57,970	54,645	48,355	40,672
Property, Plant & Equipment	56,419	36,267	36,417	44,415	37,157
Long-Term Investments	3,050	2,711	2,403	2,119	2,168
Goodwill	12,574	11,482	11,226	11,075	10,305
Other Intangible Assets	28,845	43,354	43,415	33,382	33,053
Long-Term Accounts Receivable	-	-	-	18.6	750.6
Long-Term Deferred Tax Assets	5,147	3,931	3,865	3,493	2,973
Other Long-Term Assets	1,699	1,061	1,149	2,369	892
Total Assets	179,650	156,776	153,118	145,226	127,970
Accounts Payable	24,791	15,338	15,384	11,927	10,264
Accrued Expenses	422.1	2,991	2,448	2,642	2,141
Short-Term Debt	-	9,953	11,714	13,023	6,588
Current Portion of Long-Term Debt	11,955	5,109	9,037	8,189	7,424
Current Portion of Leases	436.8	370.4	333.1	303.9	184.4
Current Income Taxes Payable	105.5	96.1	403	35.4	716.6
Current Unearned Revenue	-	45	19.6	859	452.7
Other Current Liabilities	9,872	3,760	4,355	1,451	2,564
Total Current Liabilities	47,583	37,663	43,693	38,431	30,333
Long-Term Debt	43,000	32,141	24,838	33,835	26,221
Long-Term Leases	1,354	991.6	1,180	1,019	862
Long-Term Unearned Revenue	-	295.1	238	335.6	460.3
Pension & Post-Retirement Benefits	-	485.6	322.3	205.9	125.1
Long-Term Deferred Tax Liabilities	3,582	2,484	2,292	2,193	1,920
Other Long-Term Liabilities	2,506	1,462	1,442	1,471	1,082
Total Liabilities	98,024	75,521	74,004	77,491	61,004
Common Stock	13,272	13,244	13,230	11,933	11,859
Additional Paid-In Capital	-	47,372	47,249	38,187	37,252
Retained Earnings	-	10,493	9,707	9,564	11,589
Comprehensive Income & Other	68,355	10,146	8,928	8,050	6,267
Shareholders' Equity	81,626	81,255	79,114	67,735	66,966
Total Liabilities & Equity	179,650	156,776	153,118	145,226	127,970
Total Debt	56,746	48,565	47,102	56,371	41,279
Net Cash (Debt)	-43,192	-44,480	-41,941	-50,143	-38,487
Net Cash Per Share	-32.60	-33.43	-32.68	-42.13	-32.65
Filing Date Shares Outstanding	1,260	1,324	1,323	1,193	1,186
Total Common Shares Outstanding	1,260	1,324	1,323	1,193	1,186
Working Capital	24,334	20,307	10,952	9,924	10,339
Book Value Per Share	64.78	61.35	59.80	56.76	56.47
Tangible Book Value	40,207	26,419	24,474	23,278	23,608
Tangible Book Value Per Share	31.91	19.95	18.50	19.51	19.91
Land	-	1,792	1,729	1,339	1,300
Buildings	-	20,380	18,949	15,260	11,996
Machinery	-	47,560	41,626	36,473	30,662
Construction In Progress	-	4,891	5,657	8,529	6,732

Source: S&P Global Market Intelligence. Standard template. Financial Sources.